| Literature DB >> 30607341 |
Yousef Nami1, Babak Haghshenas2, Ahmad Yari Khosroushahi3,4.
Abstract
Purpose: The increased demand for probiotics because of their health purposes provides the context for this study, which involves the molecular identification of lactic acid bacteria (LAB) obtained from the vaginal microbiota of healthy fertile women. The isolates were subjected for examination to prove their probiotic potential. In particular, the isolates were subjected to various tests, including acid/bile tolerance, antimicrobial activity, antibiotic susceptibility, Gram staining, and catalase enzyme activity assessment.Entities:
Keywords: (GTG)5 fingerprinting; Lactic acid bacteria; Molecular identification; Probiotic characterization
Year: 2018 PMID: 30607341 PMCID: PMC6311637 DOI: 10.15171/apb.2018.077
Source DB: PubMed Journal: Adv Pharm Bull ISSN: 2228-5881
Survival rate of lactic acid bacteria strains after incubation at pH value 3.0
|
|
|
| |||
|
|
|
|
| ||
| 20BL ( | 48 | 9.02 | 5.92 | 5.01 | 4.33 |
a Survival rate after 3 hour in pH value 3.0
Survival rate of lactic acid bacteria strains after incubation at 0.3 % bile salt (Oxgall)
|
|
|
| ||||
|
|
|
|
|
| ||
| 20BL ( | 68 | 9.12 | 7.73 | 7.21 | 6.84 | 6.20 |
a Survival rate after 4 hour in 0.3% bile concentration
Experiments were performed in triplicate.
The inhibitory effect of selected lactic acid bacteria against pathogenic and non-pathogenic bacteria
|
|
| ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| 13 | 0 | 16 | 0 | 3 | 0 | 0 | 14 | 0 | 13 | 19 | 17 | 0 |
0 (Resistant); 0-4 mm (Semi Resistant); 4-8 mm (Semi Susceptible); 8-12 mm (Susceptible); >12 mm (Extra Susceptible)
Antibiotic susceptibility profiles of test strains
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
| |
|
| S | S | S | S | S | S | S | S | S |
|
| S | S | I | S | S | R | R | S | R |
|
| S | S | R | S | I | S | S | R | S |
|
| S | S | R | S | S | I | R | I | R |
|
| R | S | R | R | R | S | S | S | I |
|
| S | S | S | S | R | S | S | I | R |
|
| S | R | S | S | R | I | S | S | S |
|
| S | S | S | S | I | S | I | R | R |
|
| R | R | R | R | R | R | R | R | R |
|
| S | S | R | S | S | R | S | I | S |
|
| S | S | S | S | S | S | S | S | S |
|
| R | S | I | S | I | I | S | R | S |
|
| S | S | S | R | S | S | R | S | S |
R, resistant; I, intermediate; S, sensitive
aAM, ampicillin; P, penicillin; ER, erythromycin; V, vancomycin; C, chloramphenicol; CC, clindamycin; GE, gentamycin; TE, tetracycline; SLX, sulfamethoxazol
Figure 1
Figure 2